MAPT and myeloid sarcoma: In the present study of older individuals with and without cognitive impairment, MS was used to evaluate 24 different measures of CSF tau: the concentrations of nine phosphorylated and five nonphosphorylated tau peptides, and the phosphorylation occupancy (percentage phosphorylated:nonphosphorylated) at ten sites.